Universe Pharmaceuticals INC
UPC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001809616
No open-market purchases or sales by Universe Pharmaceuticals INC insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $228.4K in total; no superinvestor holds it.
Holders of 5% or more of UPC
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Universe Pharmaceuticals INC, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Sabby Management, LLC | 13G | 9.90%727.2K shares | New | Jan 3, 20251 filing | Jan 3, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
3 Schedule 13D and 13G filings on Universe Pharmaceuticals INC, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| May 15, 20256:07 PM ET | Anson Funds Management LPand 5 others | 13G/A | 1.00%234.4K shares | −8.90 ppfrom 9.90%Below 5% | Mar 31, 2025 | SEC |
| Feb 14, 20255:24 PM ET | Anson Funds Management LPand 5 others | 13G | 9.90%782.3K shares | New | Dec 31, 2024 | SEC |
| Jan 3, 20258:51 PM ET | Sabby Management, LLCand 2 others | 13G | 9.90%727.2K shares | New | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Universe Pharmaceuticals INC shares.
No Form 144 notices for Universe Pharmaceuticals INC are on file.